ArticleAnnals of the rheumatic diseases2019

Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.

Adi Mor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.